We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFIV icon
2726
F5
FFIV
$23.4B
$20K ﹤0.01%
163
-182
-53% -$22K
GEF.B icon
2727
Greif Class B
GEF.B
$4.23B
$20K ﹤0.01%
312
+180
+136% +$11K
HIG icon
2728
Hartford Financial Services
HIG
$39.4B
$20K ﹤0.01%
+369
New +$20.1K
HQL
2729
abrdn Life Sciences Investors
HQL
$605M
$20K ﹤0.01%
+940
New +$20K
LADR
2730
Ladder Capital
LADR
$1.2B
$20K ﹤0.01%
+1,431
New +$19.2K
MKC.V icon
2731
McCormick & Company Voting
MKC.V
$14.1B
$20K ﹤0.01%
384
-94
-20% -$4.54K
MTN icon
2732
Vail Resorts
MTN
$5.39B
$20K ﹤0.01%
87
OXLC
2733
Oxford Lane Capital
OXLC
$890M
$20K ﹤0.01%
387
+373
+2,664% +$19.6K
PAM icon
2734
Pampa Energía
PAM
$4.49B
$20K ﹤0.01%
300
-600
-67% -$35.2K
SMBC icon
2735
Southern Missouri Bancorp
SMBC
$868M
$20K ﹤0.01%
+529
New +$17.2K
STX icon
2736
Seagate
STX
$190B
$20K ﹤0.01%
603
+546
+958% +$18.6K
XPH icon
2737
State Street SPDR S&P Pharmaceuticals ETF
XPH
$504M
$20K ﹤0.01%
477
-36,992
-99% -$1.57M
TCS
2738
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$20K ﹤0.01%
310
+297
+2,285% +$21K
TRHC
2739
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$20K ﹤0.01%
+734
New +$14K
VIVE
2740
DELISTED
VIVEVE MED INC
VIVE
$20K ﹤0.01%
+4
New +$24.7K
TPCO
2741
DELISTED
Tribune Publishing Company Common Stock
TPCO
$20K ﹤0.01%
1,370
-961
-41% -$12.8K
DNBF
2742
DELISTED
DNB Financial Corp
DNBF
$20K ﹤0.01%
+577
New +$19.3K
TRK
2743
DELISTED
Speedway Motorsports, Inc.
TRK
$20K ﹤0.01%
+923
New +$18.6K
BKS
2744
DELISTED
Barnes & Noble
BKS
$20K ﹤0.01%
2,601
+2,060
+381% +$15.4K
BKMU
2745
DELISTED
Bank Mutual Corp
BKMU
$20K ﹤0.01%
+1,942
New +$18.4K
BBOX
2746
DELISTED
Black Box Corp
BBOX
$20K ﹤0.01%
6,082
+3,340
+122% +$17.9K
ALOT icon
2747
AstroNova
ALOT
$226M
$19K ﹤0.01%
+1,434
New +$19.4K
ATNI icon
2748
ATN International
ATNI
$369M
$19K ﹤0.01%
366
-115
-24% -$6.87K
AVY icon
2749
Avery Dennison
AVY
$13.3B
$19K ﹤0.01%
198
-3,591
-95% -$338K
BLBD icon
2750
Blue Bird Corp
BLBD
$2.43B
$19K ﹤0.01%
942
-771
-45% -$13.8K

Similar funds

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.